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Abstract
The capacity of the antineoplastic ether lipid 1-O-octadecyl-2-O-methyl-glycero-3-phosphocholine (ET-18-OCH3) to
modulate the polymorphic properties of dielaidoylphosphatidylethanolamine has been studied using biophysical techniques.
Differential scanning calorimetry showed that ET-18-OCH3 depresses the onset of the LL to LK phase transition, decreasing
also vH of the transition. At the same time, the onset of the transition from LK to inverted hexagonal HII phase was
gradually increased as the ether lipid concentration was increased, totally disappearing at concentrations higher than 5 mol%.
Small-angle X-ray diffraction and 31P-NMR confirmed that ET-18-OCH3 induced that the appearance of the inverted
hexagonal HII phase was shifted towards higher temperatures completely disappearing at concentrations higher than 5 mol%.
These results were used to elaborate a partial phase diagram and they were discussed as a function of the molecular action of
ET-18-OCH3. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
1-O-Octadecyl-2-O-methyl-sn-glycero-3-phospho-
choline (ET-18-OCH3) is the most widely studied
member of a family of di-ether lipids, possessing a
very well known antineoplastic activity [1,2]. Recent
work has established that the cytotoxic e¡ect of
ET-18-OCH3 is due to the ability of this phospho-
lipid to induce apoptosis in sensitive cells [3^6].
Among the many processes which have been claimed
to be the targets where ET-18-OCH3 will cause phys-
iological imbalances it is important to mention the
inhibition of phosphatidylinositol phospholipase C
[7^9], protein kinase C-regulated functions [10^14],
lysophospholipid metabolism [15,16], and phospha-
tidylcholine synthesis [17^22]. Due to its hydro-
phobic nature, this molecule is expected to accumu-
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late at the membrane level, as has been described
[23], and it has also been shown to be a membrane
active anti-HIV agent [24]. Furthermore, all of the
physiological functions mentioned above are related
to cell membranes.
Therefore, although the molecular mechanism
through which this ether lipid may develop these bio-
logical activities is poorly understood, its membrane
localisation suggests that its action should be exerted
at this level by changing membrane properties or
acting as a membrane-enzyme ligand. Apart from
acting on membrane-bound enzymes [7], and inter-
fering with phospholipid synthesis [15], it has been
described that it may modulate the activity of an
enzyme which is activated by its binding to the mem-
brane as protein kinase C [10,25]. Detailed knowl-
edge of the organisation of these ether lipids in mem-
branes and their capacity to in£uence the
polymorphic phase behaviour of phospholipids may
then be relevant to their biological activities, and
necessary to understand its mechanism of action.
With this purpose several studies have been carried
out in the past. It was shown using DSC that ET-18-
OCH3 a¡ects the gel to liquid-crystalline phase tran-
sition of a number of phospholipids and increased
the membrane £uidity of HL60 leukaemic cells [26].
In another study, DSC experiments revealed that
ET-18-OCH3 a¡ected only slightly the gel to liquid-
crystalline phase transition of model membranes and
X-ray di¡raction was used to show that this ether
lipid inserted itself in the bilayer with its long axis
parallel to the membrane bilayer chains [27].
1,2-Dielaidoyl-sn-glycero-3-phosphoethanolamine
(DEPE) is a phospholipid which has been widely
used to test the capacity of membrane molecules to
a¡ect lipid polymorphism. In particular, aqueous dis-
persions of DEPE undergo a LL to LK phase transi-
tion at 36‡C and a LK to inverted hexagonal HII
transition at about 63‡C [28], and therefore it serves
to test the capacity of membrane intrinsic molecules
to insert themselves in the bilayer a¡ecting the 36‡C
transition (Tc), and the 63‡C one (TH). It was known
since long ago, that a molecule which inserts itself in
the membrane may a¡ect the biological properties of
a membrane bilayer and also the tendency to form
non-bilayer membranes. In this way, it has been es-
tablished that the e¡ect of additives on TH are at
least tenfold greater than their e¡ect on Tc [29].
In this paper we have used DSC, small angle X-ray
di¡raction and 31P-NMR to study the capacity of
ET-18-OCH3 to modulate the polymorphic proper-
ties of DEPE, showing that it a¡ected the gel to
liquid phase transition and caused the suppression
of the lamellar to inverted hexagonal HII, at concen-
trations higher than 5 mol%.
2. Materials and methods
2.1. Materials
DEPE and ET-18-OCH3, were from Avanti Polar
Lipids (Alabaster, AL). They were judged pure after
giving a single spot in thin layer chromatography,
and used without further puri¢cation. Water was
puri¢ed by passing it ¢rst through a Milli-RX appa-
ratus and afterwards through a Milli-Q apparatus,
both from Millipore.
2.2. Di¡erential scanning calorimetry
Samples of 2 mg of DEPE and the appropriate
amounts of ET-18-OCH3 were mixed in chloroform
and dried under a stream of O2-free N2, and the last
traces of solvent were removed by high vacuum for
more than 3 h. The samples were kept and dispersed
for 30 min at 50‡C, a temperature above the gel to
liquid-crystalline phase transition of the mixture, in
1 ml of 0.1 mM EDTA, 10 mM MOPS, 100 mM
NaCl bu¡er (pH 7.4), with occasional mixing in a
vortex mixer obtaining a homogeneous and uniform
suspension. The samples were then scanned in a Per-
kin Elmer DSC-4 di¡erential scanning calorimeter at
a heating rate of 4‡C/min, with a sensitivity of
1 mcal/s. The instrument was calibrated with indium
as standard, and a pan containing the same bu¡er
was used as reference. Data were obtained from the
thermograms as previously described [30]. Peak areas
were measured by weighing paper cutouts of the
peaks. After the thermal measurements, the phos-
pholipid content of the pans was determined by
phosphorus assay of perchloric acid digests [31].
2.3. Small-angle X-ray di¡raction
Samples for X-ray di¡raction analysis were pre-
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pared similarly to those described above for DSC.
10^15 mg of lipid were dried and resuspended in
1 ml of bu¡er, and spun down in a bench microfuge.
The pellet was deposited onto the di¡ractometer
sample holder.
Nickel-¢ltered Cu KK (V= 1.54 Aî ) X-ray was ob-
tained from a Philips generator, model PW1830.
X-Rays were focussed using a £at gold-plated mirror
and recorded using a linear position sensitive detec-
tor model 210 (Bio-Logic, France). Unoriented lipid
dispersions were measured in aluminium holders us-
ing Mylar windows. The sample temperature was
kept within þ 0.5‡C, using a circulating water bath.
The system was allowed to equilibrate for about
5 min at each temperature before measuring. The
X-ray exposure times were 10^15 min for each sam-
ple. The system was calibrated for the spacings using
crystalline cholesterol (33.6 Aî spacing).
2.4. 31P-NMR spectroscopy
The samples for 31P-NMR were prepared by com-
bination of organic solutions containing 20 mg of
phospholipid and the appropriate amount of
ET-18-OCH3, evaporation of the solvents and for-
mation of multilamellar vesicles, by adding 1 ml of
bu¡er, and vortexing the samples at temperatures
above the phase transition. The suspensions were
centrifuged at 10 000 rpm in a bench microfuge and
pellets were placed into conventional 5 mm NMR
tubes and 31P-NMR spectra were obtained in the
Fourier transform mode in a Varian Unity 300 spec-
trometer. All chemical shift values are quoted in
parts per million (ppm) with reference to pure lyso-
phosphatidylcholine micelles (0 ppm), positive values
referring to low-¢eld shifts. All spectra were obtained
in the presence of a gated-broad band proton decou-
pling (5 W input power during acquisition time) and
accumulated free inductive decays were obtained
from up to 5000 scans. A spectral width of 25 000
Hz, a memory of 32K data points, a 2 s interpulse
time and a 80‡ radio frequency pulse (11 Ws) were
used. Prior to Fourier transformation, an exponen-
tial multiplication was applied resulting in a 60 Hz
line broadening.
3. Results
3.1. Di¡erential scanning calorimetry
Pure DEPE presents a transition from LL lamellar
gel to LK lamellar liquid crystalline phase at 36‡C,
and a transition from lamellar liquid crystalline (LK)
to inverted hexagonal HII at 63‡C (Fig. 1). When
increasing concentrations of ET-18-OCH3 were
added to DEPE, but keeping them at low concentra-
tions such as 0.5^5 mol%, the onset of the transition
from LL to LK was gradually shifted towards lower
temperatures and the transition peak was slightly
decreased in size. An even clearer e¡ect was, how-
ever, seen on the transition from LK to HII, so that
the onset of the transition was shifted towards a
higher temperature, occurring at 68‡C at 2 mol% of
Fig. 1. DSC heating thermograms of aqueous dispersions of
ET-18-OCH3/DEPE mixtures. The mol% of ET-18-OCH3 in
the mixture with respect to total phospholipid is indicated on
each thermogram.
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ET-18-OCH3 and at 76‡C at 5 mol%. In addition to
that, at 5 mol% of ET-18-OCH3 the LL to LK was
clearly widened and the onset temperature decreased,
with a small peak appearing at 26‡C. At 10 mol% of
ET-18-OCH3 the LL to LK transition was decreased
in temperature and in size, and appeared overlapped
to another peak with its onset at 26‡C which was
already seen in the 5 mol% sample, and the LK to
HII completely disappeared. A pattern very similar to
that observed at 10 mol% was observed at 17 mol%,
with a further increase of the 26‡C transition at the
expense of the LL to LK transition whose area was
decreased. At 30 mol% the same trend was observed,
with the peak which has its onset at 26‡C increasing
in size at the expense of the other one, so that as a
consequence of being shifted to a lower temperature
both peaks appeared overlapped.
In Fig. 2, vH of the transitions are plotted versus
ET-18-OCH3 mol% contents. It can be seen that
there was a certain decrease of vH of the LL to LK
transition as the ether concentration increased, going
from 8 kcal/mol in pure DEPE to 4.8 in the sample
containing 30 mol%. On the other hand, vH of the
LK to HII phase transition went down to nil at
10 mol% (see insert of Fig. 2). It should be pointed
out that the LK to HII phase transition which was not
detected at all at 10 mol% might be shifted to higher
temperatures, beyond the limit of our scan. This shift
would follow the trend seen at lower temperatures,
where the transition was shifted 8‡C when the con-
centration of the ether was increased from 2 mol% to
5 mol% (see Fig. 1).
3.2. Small angle X-ray di¡raction
In order to get information about the structural
organisation of the DEPE/ET-18-OCH3 systems
small angle X-ray di¡raction was used. The di¡racto-
grams obtained were symmetrical as expected for the
non-oriented samples used, nevertheless only one
side of the di¡ractograms was considered in Fig. 3.
The data are presented in a logarithmic scale for
better clarity. Pure DEPE (Fig. 3A) presented a
d-spacing of 66.8 Aî at 30‡C, corresponding to LL.
DEPE presented only the ¢rst order re£ection and
this is in agreement with previous observations [32].
The d-spacing not only informs about the phase or-
ganisation of the lipids but also about the interbi-
layer repeat distance which is indicated by the ¢rst
order repeat distance. This distance is, however, the
addition of the bilayer thickness plus the thickness of
the water layer between the lipid bilayers. At 50‡C
the d-spacing decreased to 51.5 Aî , corresponding to
the LK phase. Therefore the LL to LK phase transi-
tion is accompanied by a 15.3 Aî decrease in the ¢rst
order repeat distance and hence in the interbilayer
repeat distance. This is to be expected knowing
that the gel to liquid crystalline phase transition gives
place to a bigger £uctuation of acyl chains and hence
to a decrease in their e¡ective chain length. At 70‡C
the pattern changed considerably with a ¢rst order at
65.2 Aî , a second one at 37.4 Aî and a third one at
33.0 Aî , this series being related with the ratios 1:1/
k3:1/2, corresponding to an inverted hexagonal HII
phase [33]. At 80‡C the d-spacings were also typical
of a HII phase with 62.3, 35.9, 31.8 Aî . In lipidic
systems organised in an inverted hexagonal HII sys-
tem the ¢rst order re£ection obtained from its small
angle X-ray di¡ractogram is related to the diameter
of the lipidic cylinders (denoted by c) by the expres-
sion d = (k3/2)Wc. According to the spacings given
above, pure DEPE at 70‡C has a c of 75.3, which
decreased to 71.9 Aî at 80‡C.
The presence of 2 mol% of ET-18-OCH3 (Fig. 3B)
Fig. 2. vH of the LL to LK phase transition of mixtures with
di¡erent mol% of ET-18-OCH3. The same data with respect to
the LK to HII phase transition are plotted in the insert.
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did not appreciably change the pattern of pure
DEPE with a d-spacing of 67.6 Aî . At 50‡C the
pattern was also similar to that of pure DEPE at
the same temperature with a d-spacing of 52.4 Aî .
At 70‡C this sample presented a predominantly la-
mellar pattern of 51.9 Aî , but given the noise of the
di¡ractogram and the decrease in intensity of the
¢rst order re£ection, it cannot be excluded that at
least a small percentage of the lipids could be organ-
ised in an inverted hexagonal HII structure. Such a
HII structure seems to be very clearly indicated by
the pattern obtained at 80‡C with d-spacings at 65.2,
36.7 and 32.6 Aî which reveals an increase of c (di-
ameter of the cylinders) to 75.2 Aî in comparison
with pure DEPE which shows 71.9 Aî at the same
temperature. It can be suggested that this is the result
of introducing a positive curvature agent into the
membrane that increases the intrinsic radius of cur-
vature.
At 5 mol% of ET-18-OCH3 (Fig. 3C), an increase
in the d-spacing was observed at 30‡C, i.e. below the
phase transition from LL to LK with a ¢rst order
d-spacing of 70.1 Aî , i.e. higher than that of pure
DEPE, a second order d-spacing at 35.9 Aî and a
third one at 24.2 Aî . The d-spacing at 50‡C was
with 55.5 Aî also higher than that of pure DEPE at
the same temperature. At 70‡C and 80‡C this sample
presented di¡ractograms with the ¢rst spacing at
56.1 and 54.5 Aî , respectively, which may correspond
to lamellar structures.
Finally, the sample containing 17 mol% of ET-18-
OCH3 presented a peculiar behaviour (Fig. 3D). At
30‡C the d-spacing was rather large with 72.8 Aî . The
same can be said of the 50‡C di¡ractogram with a
¢rst order at 66.8 Aî and a second one at 3.28 Aî .
Exactly the same d-spacings were observed at 50‡C
and at 80‡C; the ¢rst order was at 65.2 and the
second one at 32.2 Aî . All these d-spacings can be
originated from lamellar structures but for some rea-
sons the spacings are clearly bigger than those of
pure DEPE, and they showed second order spacings,
all of that indicating that these lamellar structures
were di¡erent from those of pure DEPE when organ-
ised in either Lb or LK phase.
Fig. 3. Small angle X-ray di¡ractograms obtained from ET-18-OCH3/DEPE mixtures, at the temperatures shown and at di¡erent
mol% of ET-18-OCH3 : (A) 0; (B) 2; (C) 5; (D) 17. The data of d-spacings in Aî are plotted in a logarithmic scale.
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3.3. 31P-NMR spectroscopy
The e¡ect of ET-18-OCH3 on the phase behaviour
of DEPE was investigated by means of 31P-NMR.
Phospholipids produce a characteristic asymmetrical
31P-NMR line-shape with a high-¢eld peak and a
low-¢eld shoulder when they are organised in bilayer
structures with a residual chemical shift anisotropy
(vc) of approx. 64 ppm in the gel state and approx.
42 ppm in the liquid-crystalline state [34,35]. This is
the case for pure DEPE (Fig. 4A), showing a vc of
65 ppm at 30‡C (gel state), and 45 ppm at 55‡C
(liquid-crystalline). However, in the hexagonal HII
phase, due to rapid lateral di¡usion of the phosho-
lipids around the tubes of which this phase is com-
posed, the chemical shift anisotropy is averaged re-
sulting in a shape with reverse asymmetry when
compared to the bilayer line-shape, so that now there
is a high-¢eld shoulder and a low-¢eld peak with an
approx. 2-fold reduction in the absolute value of vc
to about 20 ppm [28,36]. This pattern can be seen for
Fig. 4. 31P-NMR spectra of aqueous dispersions of mixtures of ET-18-OCH3 with DEPE at the temperatures shown. The mol% con-
tents of ET-18-OCH3 in each sample were as follows: (A) 0; (B) 2; (C) 5; (D) 17.
Fig. 5. Phase diagrams for aqueous dispersions of ET-18-
OCH3/DEPE mixtures, based on data derived from DSC,
X-ray di¡raction and 31P-NMR. The closed and open circles
were obtained from Tc of the onset and completion tempera-
tures of the heating scans respectively. LK and LL have their
usual meaning and I stands for isotropic as judged from 31P-
NMR.
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pure DEPE (Fig. 4A) at 70‡C and at 80‡C, with vc
of 20 ppm in both cases.
The presence of 2 mol% of ET-18-OCH3 (Fig. 4B)
did not produce a signi¢cant perturbation either in
the gel state at 30‡C or in the £uid liquid-crystalline
state at 50‡C with spectra showing lamellar patterns.
At 70 and 80‡C isotropic components appeared
superimposed on asymmetric spectra characteristic
of inverted hexagonal HII phases. The addition of
5 mol% of ET-18-OCH3 (Fig. 4C) did not alter the
spectrum of pure DEPE at 30‡C, i.e. in the lamellar
gel state, but a variation appeared in the liquid-crys-
talline state, at 50‡C, because an isotropic compo-
nent appeared superimposed to a lamellar pattern.
At 70‡C and 80‡C the spectra were similar to that
of 50‡C, although the isotropic component had dif-
ferent intensities. At 17 mol% of ET-18-OCH3 (Fig.
4D) the spectra were very similar at all the temper-
atures studied, 30, 50, 70 and 80‡C, with an isotropic
peak superimposed on a lamellar component.
4. Discussion
We have studied the in£uence of the antineoplastic
molecule ET-18-OCH3 on the thermotropic proper-
ties of DEPE membranes, with the aim of advancing
our knowledge of the way in which this ether lipid
may alter the physical properties of membranes. It
has been possible to show that ET-18-OCH3 a¡ected
both the LL to LK and the LK to HII phase transitions
presented by pure DEPE.
The results obtained through DSC were used as
the base to construct a partial phase diagram, and
the onset and completion temperatures of both the
LL to LK and the LK to HII phase transitions were
used to de¢ne the line boundaries of both transitions.
The data from X-ray di¡raction and 31P-NMR were
also used to specify the type of phase present in each
zone. It can be seen in Fig. 5 that an immiscibility
appeared in the gel phase with a horizontal solidus
line at concentrations higher than 5 mol% which cor-
responded to the appearance of a small peak at
5 mol% in the DSC thermograms. The nature of
this small peak is not clear. On the other hand, the
£uidus line indicated a good mixing in the £uid con-
dition.
Isotropic phases were found trough 31P-NMR in a
number of cases. The origin of these isotropic peaks
is uncertain, and it could arise from small particles,
or from certain areas of the membrane with a very
high curvature [37,38]. In the 2% sample where iso-
tropic peaks superimposed to anisotropic spectra
characteristic of inverted hexagonal HII phases were
observed at 70 and 80‡C, it should be concluded that
the isotropic signal must come from lipids physically
separated from the tubules, forming mixed micelles
containing the ether lipid. The formation of mixed
micelles would be compatible with the observed de-
crease in vH (Fig. 2), since phospholipids incorpo-
rated in these micelles would not undergo the gel to
liquid crystalline transition.
With respect to the LL to LK transition, DSC ex-
periments clearly showed that the ether lipid de-
pressed both the transition temperature and vH.
DSC also showed that very low concentrations of
ET-18-OCH3 produced an increase in the transition
temperature of the LK to HII phase transition, so that
this transition was no longer seen at concentrations
of 5 mol% and higher. Small-angle X-ray di¡raction
con¢rmed that at concentrations of ET-18-CH3 of
5 mol% and higher the inverted hexagonal HII phase
was not formed at 80‡C. In its place a bilayer phase
was observed which presented a d-spacing di¡erent
to that of pure DEPE in the LK phase (50‡C). In fact,
samples containing ET-18-OCH3, in the LL phase
also had a higher d-spacing than pure DEPE (Fig.
3). It is not possible to distinguish whether these
increases in d-spacing were due to either an increase
in the bilayer thickness or in the water layer between
two di¡erent bilayers. Nevertheless, it seems much
more likely that the ET-18-OCH3 increases hydra-
tion. It lowers Tc and therefore likely increases acyl
chain gauche rotamers, decreasing bilayer thickness.
This ether lipid has a phosphatidylcholine-type head-
group which binds much more water than does PE.
Therefore it almost certainly increases the d-spacing
by increasing the water layer.
Non-bilayer lipid phases such as the inverted hex-
agonal HII phase (see [39] for a review on the struc-
ture of the HII phase) have been related to a great
variety of biological processes [40]. Compounds that
have a large hydrophobic volume and a small polar
headgroup will tend to destabilise membrane bi-
layers, eventually leading to the formation of a
non-bilayer inverted hexagonal (HII) phase, and on
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the contrary, compounds with a polar part larger
than the hydrophobic one will tend to stabilise the
bilayer structure [41,42]. It is interesting to remark in
this context that ET-18-OCH3 is an asymmetrical
molecule with a relatively large polar group and a
relatively small hydrophobic part, since it has only
one chain with a length comparable to the most com-
mon membrane phospholipids, and the other chain
possesses only one methyl group. This is an inverted
cone-shaped molecule which is hence expected to sta-
bilise lamellar phases [41].
According to a large number of studies the ten-
dency to form non-bilayer lipid structures can be
associated with increasing activities of enzymes de-
pending on membranes such as phospholipase A2
[43] and protein kinase C [44]. Note that it is the
tendency rather than the presence of these non-bi-
layer structures that is blamed to facilitate the activ-
ity of these enzymes. This tendency has been actually
measured through the decrease in the LK to HII tran-
sition (TH) in phospholipids such as POPE and
DEPE by Epand and co-workers [45^47]. This way
was used to predict the activating or inhibiting e¡ect
of a number of compounds on PKC: those decreas-
ing TH will be expected to be activators (such as
5L-cholan-24-ol or eicosane) and those increasing
TH will be expected to behave as inhibitors (such
as Z-Gly-Leu-NH2, or cyclosporin A). Using this
logic, ET-18-OCH3 should be expected to behave
as an inhibitor of PKC. Contradictory results have
been obtained, however, in this respect. Whereas
some authors have claimed that ET-18-OCH3 will
indeed inhibit PKC, at least in vitro [10,25,48], others
have found inhibition or activation of PKC in vivo,
depending on the way of preparing the lipid disper-
sions used in the PKC assays [49]. A possible way of
reconciling these contradictory results could be to
consider that ET-18-OCH3 belongs to a class of com-
pounds which may act as solubilisers at high enough
concentrations, being similar to detergents. Since act-
ing like that they will destabilise the bilayer, they
could act then as activators of enzymes such as phos-
pholipases and PKC. It has been observed in fact
that similar molecules as lysophospholipids can
both activate and inhibit PKC depending on the con-
centration [50], and this biphasic e¡ect may be due to
their diverse e¡ects on membranes. A lot of caution
should be taken when trying to compare experiments
on activation/inhibition of enzymes like PKC, carried
out at di¡erent concentrations of molecules like ET-
18-OCH3.
We want to stress that the stabilisation of mem-
brane bilayers and the formation of non-bilayer
structures are not necessarily the only ways in which
ET-18-OCH3 may a¡ect cell membranes. It has been
previously suggested, for example, that membrane
permeabilisation [51] and alteration of membrane £u-
idity [23,26] could be implicated, and other addition-
al perturbations of the membranes may be associated
to these e¡ects.
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